Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center.
All patients admitted to our tertiary care hospital from 1 December 2007 to 10 June 2008 were screened for methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) nasal colonization, and the isolates were tested for mupirocin susceptibility by using Etest. Mupirocin resistance (MR) was noted to occur in 3.4% of MRSA carriers, and high-level MR was noted to occur in 0.62% of carriers.
Babu
Tara
T
Loyola University Health Systems, Maywood, IL 60153, USA.
Rekasius
Violeta
V
Parada
Jorge P
JP
Schreckenberger
Paul
P
Challapalli
Malliswari
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002353:Carrier State / Q000382:microbiology*; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D016712:Mupirocin / Q000494:pharmacology*; D009297:Nasal Mucosa / Q000382:microbiology; D013203:Staphylococcal Infections / Q000382:microbiology*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D016712:Mupirocin